Sara Carvalho
Founding Scientist Nanograb
Sara Carvalho is a Founding Scientist at Nanograb, where she established the company’s wet-lab research programme and leads experimental R&D focused on lipid nanoparticle development. Her expertise spans LNP production, functionalisation, characterisation and quality control, with experience designing and coordinating in vivo studies to support preclinical development and pharmaceutical collaborations. Since joining Nanograb in 2024, Sara has played a key role in advancing the company’s technology, generating critical in vivo data and contributing to two patent filings. She previously worked as a Product Development Consultant at ZymeDx.
Seminars
Friday 19th February 2027
Developing Cell-Specific or Organ-Specific Delivery Using Targeting Ligands & Surface Modifications to Avoid Off-Target Toxicity
11:30 am
- Leveraging biophysics-informed AI to design combinations of peptide binders for cell-specific LNP targeting, moving beyond conventional single-receptor approaches
- Conjugating targeting moieties such as ligands, antibodies & short linear peptides to LNP surfaces to achieve cell-specific or tissue-specific delivery
- Developing scalable, multi-peptide LNP targeting strategies to enable extrahepatic mRNA delivery across different cell types and therapeutic applications
